Alan Forrest

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Alan Forrest, David E. Nix, Charles H. Ballow et al. · Antimicrobial Agents and Chemotherapy · 1993 · 1.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +16

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 931 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia

George Sakoulas, Pamela A. Moise-Broder, Jerome J. Schentag et al. · Journal of Clinical Microbiology · 2004 · 836 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

Pamela A. Moise-Broder, Alan Forrest, Mary C. Birmingham et al. · Clinical Pharmacokinetics · 2004 · 749 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

Paul G. Ambrose, Sujata M. Bhavnani, Christopher M. Rubino et al. · Clinical Infectious Diseases · 2006 · 700 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17